Cognate BioServices Inc., a premier commercial-ready, global CDMO in the Cell and Gene Therapy industry, has announced plans to expand cell and gene therapy manufacturing capacity, laboratory space, warehousing capabilities, and increase office support at its facilities in the United States and Europe.   The expansion activities will nearly double the capacity at Cognate’s existing Global Manufacturing Facility & Headquarters, located only minutes from Memphis International Airport. In...